Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Indwelling Catheter for Total Shoulder Replacement
NCT03827213Phase 2Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine in postoperative pain, sponsored by Montefiore Medical Center. Primary endpoint: Opioid Requirements Assessed at 24 Hours Post-surgery. Started Jan 2019; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03827213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827213.